General classes of vaccines An induced mobilization of the immune response for the purpose of...
-
Upload
delilah-butler -
Category
Documents
-
view
213 -
download
0
Transcript of General classes of vaccines An induced mobilization of the immune response for the purpose of...
General classes of vaccines
An induced mobilization of the immune response for the purpose of therapeutic benefit.
Preventative: infectious agents
Therapeutic: cancer
General classes of vaccines
Antibody responseCD4+ T cells, B cellsMHC class II-dependent
Cellular responsecytotoxic CD8+ T cells,
NK cellsMHC class I-dependent
Classical success: polio virus
• vaccine: killed/attenuated virus• injected (Salk)• oral (Sabin)
• oral route of infection• initial replication in GI tract
Paroxysmal success: influenza
• killed/attenuated virus, protein• antibody to viral spike glycoprotein (hemagglutinin, HA) confers protection
• infects via airway• epithelial/systemic replication
HA genetic drift subverts antibody
Unmitigated failure: HIV
• killed/attenuated virus• recombinant envelope glycoprotein• poor protection, cumbersome trials
• infects via anal/vaginal epithelia• replication/residence in immune cells
>80 million infected individuals/victims
3.1 million new cases/year in Africa alone
Why have HIV vaccines failed?
• gp120 genetic drift subverts antibody• virus is rarely extracellular• wrong viral component, wrong delivery?• underdesigned?• or…overdesigned?
Typical antigen formulations
• peptides bound to carriers (adjuvants)
• recombinant proteins
• killed or attenuated virus/bacteria
• DNA or mRNA encoding protein antigen
Typical vaccine delivery vehicles
• injection in adjuvant (skin, muscle)
• oral, nasal
• recombinant or synthetic viral vector
• transformed microbial vector
Engineering rational vaccines
• understand biology of target• understand biology of response
bioengineering
Production of MHC class I & II-peptide complexes
Virus-encoded proteins
“Cross presentation” of exogenous antigens on MHC class I: CD8 responses
to extracellular agents
Dendritic cells initiate antigen-specific immune
responses• most efficient of all APCs
• high MHC class I, II & costimulators
• efficient cross presentation
• stimulate naïve T cells (CD4, CD8)
initiate Ag-specific immune responses
All immunization strategies must target DCs
Immature:antigencapture
Mature:antigen
presentation
immature DC mature DC
Multiple inducers of DC maturation
various T cell responses
Microbial products / TLR ligandsViral productsInflammatory cytokinesSignaling receptors
Targeting DCs to elicit immunity: engineering requirements
• The optimal delivery device…
• will be targetable to selected DC populations
• can be coupled to DC maturation agents (microbial, inflammatory,
other?)
• can accomodate any type of antigen
• permits intracellular targeting (cross-presentation from cytosol favors cytotoxic T cell responses)
• traceable (does it reach DCs, nodes?)
• modular (permits efficient, small-scale trials)
• synthetic, stable, orally available for global use